Brief Report - (2025) Volume 9, Issue 4
Received: 01-Jul-2025, Manuscript No. fsb-26-189954;
Editor assigned: 03-Jul-2025, Pre QC No. P-189954;
Reviewed: 17-Jul-2025, QC No. Q-189954;
Revised: 22-Jul-2025, Manuscript No. R-189954;
Published:
29-Jul-2025
, DOI: 10.37421/2577-0543.2025.9.240
Citation: ElSayed, Ahmed. ”Advancing Transdermal Drug Delivery: Smart Technologies and Materials.” J Formul Sci Bioavailab 09 (2025):240.
Copyright: © 2025 ElSayed A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use distribution and reproduction in any medium, provided the original author and source are credited.
Recent advancements in transdermal drug delivery systems (TDDS) are significantly focused on improving drug permeation and overcoming the inherent barrier properties of the skin. Innovative strategies are being developed to enhance drug bioavailability and achieve controlled release profiles, offering a non-invasive alternative to traditional administration routes [1].
Microneedle technology, especially dissolving microneedles, is emerging as a powerful tool for delivering large molecules like peptides and proteins transdermally. These systems create temporary pathways in the stratum corneum, facilitating drug passage while minimizing patient discomfort. Ongoing research aims to refine fabrication methods and materials for optimized drug loading and release kinetics [2].
Iontophoresis is another key technology leveraging an electric field to enhance the transdermal transport of charged drugs. Current innovations in this area focus on improving electrode materials, waveform design, and device portability to increase delivery efficiency and patient comfort. This method is effective for both hydrophilic and lipophilic compounds [3].
Sonophoresis, which uses ultrasound energy, is being explored for its capacity to transiently increase skin permeability. Researchers are investigating optimal ultrasound parameters and carrier systems, such as microbubbles and liposomes, to enhance the delivery of various therapeutic agents, offering a non-invasive penetration method [4].
Nanotechnology plays a pivotal role in the evolution of TDDS, with nanoemulsions, liposomes, and polymeric nanoparticles being engineered for improved drug solubility and skin penetration. These nanocarriers can enhance drug localization and systemic circulation, leading to better efficacy and fewer side effects through tailored properties for controlled release [5].
The development of smart TDDS represents a significant area of innovation, featuring systems that respond to physiological stimuli or external triggers for controlled drug release. Examples include thermomechanical and pH-sensitive patches designed for targeted delivery and optimized therapeutic responses [6].
Permeation enhancers are critical for TDDS, and research continues to identify novel, safe, and effective options. This includes exploring natural compounds, bio-based lipids, and synergistic combinations to transiently and safely disrupt the skin barrier, thereby expanding the therapeutic applications of transdermal delivery [7].
Advanced materials, such as stimuli-responsive polymers and biodegradable scaffolds, are enabling more sophisticated drug delivery profiles within TDDS. These materials can be engineered for specific release rates or in response to environmental cues, enhancing efficacy and patient compliance through innovative polymer chemistry [8].
Formulation strategies for transdermal delivery are constantly evolving to accommodate a wider range of drug molecules, including hydrophobic drugs and biologics. The incorporation of penetration enhancers, solubilizers, and stabilizers in optimized matrices is essential for achieving desired drug release and permeation, with ongoing exploration of novel excipients and architectures [9].
The integration of wearable technology and the Internet of Things (IoT) with TDDS is a growing trend. Smart patches with integrated sensors can monitor physiological parameters and adjust drug release, creating personalized and responsive therapeutic systems for chronic disease management and advanced drug therapy [10].
Recent innovations in transdermal drug delivery systems (TDDS) are centered on enhancing drug permeation and overcoming the skin's natural barrier properties. Novel approaches such as microneedle arrays, iontophoresis, and sonophoresis are being developed alongside advanced formulations like nanoemulsions and liposomes. These technologies aim to improve drug bioavailability, enable controlled and sustained release, and broaden the spectrum of drugs suitable for transdermal application, presenting a non-invasive alternative to oral or parenteral routes [1].
Microneedle technology, particularly dissolving microneedles, is emerging as a promising strategy for the transdermal delivery of macromolecules such as peptides and proteins. These systems function by creating transient pores in the stratum corneum, which facilitates drug passage while minimizing pain. Extensive research is dedicated to exploring various fabrication methods and materials to optimize drug loading, release kinetics, and skin penetration for superior therapeutic outcomes [2].
Iontophoresis utilizes an electric field to enhance the transdermal transport of charged drugs. Recent advancements in this field are focused on optimizing electrode materials, waveform designs, and device portability to improve drug delivery efficiency and patient comfort. This method is particularly effective for delivering both hydrophilic and lipophilic drugs across the skin barrier, offering a precisely controlled and dose-adjustable delivery approach [3].
Sonophoresis, which employs ultrasound energy, is being investigated for its potential to transiently increase skin permeability. Current studies are focused on identifying optimal ultrasound parameters and carrier systems, including microbubbles and liposomes, to enhance the delivery of therapeutic agents. This technique provides a non-invasive method for improving the penetration of a wide array of drugs, encompassing both small molecules and peptides [4].
Nanotechnology plays a critical role in the progression of TDDS. Nanoemulsions, liposomes, and polymeric nanoparticles are being meticulously engineered to encapsulate drugs, boost their solubility, and facilitate skin penetration. These nanocarriers enhance drug localization to deeper skin layers or systemic circulation, leading to improved therapeutic efficacy and a reduction in adverse effects, with tailored nanoparticle properties enabling controlled release profiles [5].
The development of smart TDDS is a significant area of innovation, characterized by systems that respond to physiological stimuli or external triggers to release drugs in a controlled manner. Examples include thermomechanical systems that release drugs upon temperature fluctuations and pH-sensitive patches. Such intelligent designs aim to achieve targeted drug delivery and optimize therapeutic responses based on individual patient needs [6].
Permeation enhancers are indispensable components in TDDS, and ongoing research strives to identify novel, safe, and highly effective enhancers. This includes the exploration of natural compounds, bio-based lipids, and synergistic combinations of existing enhancers. The primary objective is to transiently disrupt the skin barrier without inducing irritation or damage, thereby facilitating drug permeation for a broader therapeutic spectrum [7].
The application of advanced materials in TDDS, including stimuli-responsive polymers and biodegradable scaffolds, is paving the way for more sophisticated drug delivery profiles. These materials can be designed to release drugs at specific rates or in response to environmental cues, thereby enhancing therapeutic efficacy and patient compliance. Innovations in polymer chemistry are instrumental in developing highly functional transdermal patches [8].
Formulation strategies for transdermal delivery are continually evolving to accommodate a wider range of drug molecules, including challenging hydrophobic drugs and complex biologics. The incorporation of penetration enhancers, solubilizers, and stabilizers within optimized matrices is key to achieving the desired drug release and permeation. Current research is exploring novel excipients and sophisticated formulation architectures for improved performance [9].
The integration of wearable technology and the Internet of Things (IoT) with TDDS is an emerging and promising trend. Smart patches equipped with integrated sensors can monitor physiological parameters and adjust drug release accordingly, thereby creating personalized and responsive therapeutic systems. This convergence holds the potential to revolutionize chronic disease management and drug therapy through real-time feedback and precise control mechanisms [10].
Transdermal drug delivery systems (TDDS) are advancing through innovations in microneedle technology, iontophoresis, sonophoresis, and nanotechnology using nanoemulsions, liposomes, and nanoparticles to enhance drug permeation and bioavailability. Smart TDDS and advanced materials like stimuli-responsive polymers are enabling controlled and targeted drug release. Permeation enhancers and sophisticated formulation strategies are crucial for accommodating a wider range of drugs. The integration of wearable technology and IoT promises personalized and responsive therapeutic systems, offering a non-invasive and efficient alternative to traditional drug administration.
None
None
Journal of Formulation Science & Bioavailability received 23 citations as per Google Scholar report
